YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)
Lyrica
Lyrica May Be Linked to Suicide
Keywords: Lyrica Suicide Side Effects Lawyer Lawsuit Neurontin
Lyrica & Neurontin AssociationLyrica (Generic: Pregabalin) is prescribed to patients for the management of neuropathic pain associated with diabetic peripheral neuropathy. Lyrica, manufactured by Pfizer, received FDA approval on December 30, 2004. Seizure patients also use Lyrica. Lyrica was manufactured as a substitute medication for Neurontin. Lyrica has only been tested and prescribed to adults 18 or older. Lyrica has not been studied in children under the age of 18. Lyrica, just like Neurontin, may cause increased risk of suicide and suicidal behavior.
Other Lyrica Side Effects
General side effects associated with Lyrica can include: dizziness, blurred vision, sleepiness, weight gain, swelling (edema), muscle problems, and altered perception. Weight gain is of particular concern to those with diabetes, as this can worsen their condition. Additional animal studies also found Lyrica to cause side effects in males. Lyrica lowered the fertility of some male animal subjects throughout testing. Males who received Lyrica who did reproduce had an increased risk of birth defects in their offspring.
Free Lawsuit Case Evaluation
If you or a loved one took Lyrica and suffered side effects, please fill out the form at the right for a free case evaluation by a qualified drug side effects attorney.
LyricaRSS Feed
Baystate Medical Center Subpoenaed Over Fake Drug Studies
Apr 8, 2009 | Parker Waichman Alonso LLP
The Baystate Medical Center has received a subpoena as part of a federal investigation into a doctor there who falsified 21 drug studies. According to The Wall Street Journal, the U.S. Attorneys office in Boston is seeking financial records related to the work of Dr. Scott S. Reuben. As we reported last month, medical journals have been asked to retract studies involving Vioxx, Celebrex, Lyrica and other drugs. All of the studies were published between 1996 and 2008. According...
Researcher Faked Data for 21 Studies Involving Vioxx, Celebrex and Other Drugs
Mar 11, 2009 | Parker Waichman Alonso LLP
Medical journals have been asked to retract 21 studies that touted the benefits of Vioxx, Celebrex and other drugs. According to The Wall Street Journal, Baystate Medical Center, Springfield, Mass. is asking the journals to make the retractions because its former chief of acute pain, Dr. Scott S. Reuben, had faked data used in the studies.In addition to Vioxx and Celebrex, some of the 21 studies involved the fibromyalgia drug Lyrica and the antidepressant Effexor XR. Reuben's...
Lyrica, Cymbalta Fibromyalgia Promotions Questioned
Feb 9, 2009 | Parker Waichman Alonso LLP
Two drug makers are spending a fortune to promote medications for a disease that some doctors say may not even exist. According to the Associated Press, Eli Lilly and Pfizer have donated more than $6 million to nonprofit groups to spread information about fibromyalgia in an effort to boost sales of Cymbalta and Lyrica.Fibromyalgia, defined as a chronic, widespread pain condition of unknown origin, is a controversial diagnosis. No biological tests exist to diagnose...
Epilepsy Drugs to Carry Suicide Warnings
Dec 17, 2008 | Parker Waichman Alonso LLP
Epilepsy drugs must now carry warnings about their suicide risks, the Food & Drug Administration (FDA) has announced. The drugs subject to the new warning include those used to treat psychiatric disorders, migraine headaches and other conditions, as well as epilepsy. Epilepsy drugs on the list are:Carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR) Clonazepam (marketed as Klonopin) Clorazepate (marketed as Tranxene) Divalproex sodium (marketed as Depakote,...
Epilepsy Drugs Targeted for Black Box Suicide Warning
Jul 8, 2008 | Parker Waichman Alonso LLP
Federal regulators want the makers of epilepsy drugs to add a black box warning to their labels about their association with suicidal thoughts and behavior. The Food & Drug Administration (FDA) is set to ask an outside advisory panel for its recommendations on the proposed black box at a meeting this Thursday. In total, 11 epilepsy drugs could get the new black box warning - the FDA's strongest safety notice. They include:Carbamazepine (marketed as Carbatrol, Equetro, Tegretol,...
Lyrica
Quick Facts
Lyrica Reference Guide
Generic Name
Pregabalin
Date Approved
December 30, 2004
Manufacturer
Pfizer
Status
On the market
Approved Uses
Diabetic peripheral neuropathy
Seizures
Serious Side Effects
Suicide
Suicidal behavior
Death Related Topics
Neurontin
Diabetes
Defective Drugs
Diseases
Pregabalin
Date Approved
December 30, 2004
Manufacturer
Pfizer
Status
On the market
Approved Uses
Diabetic peripheral neuropathy
Seizures
Serious Side Effects
Suicide
Suicidal behavior
Death Related Topics
Neurontin
Diabetes
Defective Drugs
Diseases
News Feeds
WE ALSO OFFER OUR FIRM NEWS AS RSS/XML FEEDS.
LEARN MORE ABOUT RSS
